Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
European Journal of Cancer (Oxford, England : 1990)|June 21, 2021
Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (Telomelysin) with radiotherapy in oesophageal cancer patients unfit for standard treatmentsYasuhiro Shirakawa, Hiroshi Tazawa, Shunsuke Tanabe, et al.
Scientific Reports|January 19, 2021
Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancerRyoichi Katsube, Kazuhiro Noma, Toshiaki Ohara, et al.
Annals of Surgical Oncology|September 12, 2024
Usefulness of an Artificial Intelligence Model in Recognizing Recurrent Laryngeal Nerves During Robot-Assisted Minimally Invasive EsophagectomyTasuku Furube, Masashi Takeuchi, Hirofumi Kawakubo, et al.
Cancers|October 29, 2025
Tertiary Lymphoid Structures Are Associated with Favorable Clinical Outcomes and Negatively Correlated with Cancer-Associated Fibroblasts in Esophageal CancerTomoyoshi Kunitomo, Kazuhiro Noma, Noriyuki Nishiwaki, et al.
Esophagus : Official Journal of the Japan Esophageal Society|June 6, 2024
Comparison of proton-based definitive chemoradiotherapy and surgery-based therapy for esophageal squamous cell carcinoma: a multi-center retrospective Japanese cohort studyKoichi Ogawa, Hitoshi Ishikawa, Takeshi Toyozumi, et al.
Molecular Therapy. Oncology|May 15, 2024
Functional remodeling of intraperitoneal macrophages by oncolytic adenovirus restores anti-tumor immunity for peritoneal metastasis of gastric cancerMotoyasu Tabuchi, Satoru Kikuchi, Hiroshi Tazawa, et al.
Cancer Letters|June 9, 2023
Dual antiplatelet therapy inhibits neutrophil extracellular traps to reduce liver micrometastases of intrahepatic cholangiocarcinomaMasashi Yoshimoto, Shunsuke Kagawa, Hiroki Kajioka, et al.
Cancer Letters|December 25, 2018
Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancerSho Takeda, Kunitoshi Shigeyasu, Yoshinaga Okugawa, et al.
Cancer Chemotherapy and Pharmacology|January 1, 2018
A multi-institution phase II study of docetaxel and S-1 in combination with trastuzumab for HER2-positive advanced gastric cancer (DASH study)Shunsuke Kagawa, Atsushi Muraoka, Takeshi Kambara, et al.
Molecular Therapy. Oncology|February 2, 2026
Collagen depletion by pirfenidone enhances antitumor effect of oncolytic adenovirus against peritoneal metastases of gastric cancerTomohiro Okura, Satoru Kikuchi, Hiroshi Tazawa, et al.
Pageof 15